Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × HhAntag691 × Clear all

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Skin Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Basal Cell 1

Interventions

pembrolizumab 46 Specimen Handling 30 Magnetic Resonance Spectroscopy 27 Biopsy 26 Radiosurgery 19 Gemcitabine 14 Nivolumab 13 Cisplatin 13 Paclitaxel 11 Carboplatin 11 Cyclophosphamide 10 Taxes 9 Pemetrexed 9 Leucovorin 9 Irinotecan 9 Fluorouracil 9 Capecitabine 9 Oxaliplatin 8 Drug Therapy 8 Doxorubicin 8 Cetuximab 8 Bevacizumab 8 trastuzumab deruxtecan 7 Radiotherapy 7 olaparib 6 cemiplimab 6 abemaciclib 6 Standard of Care 6 Folfox protocol 6 Docetaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04817956 2024-02-29

IMPRESS-N

Oslo University Hospital

Phase 2 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡